GENESIS Biomed is part of the EU-funded PHEMS project consortium to develop a new federated data-driven collaboration among European pediatric hospitals ... 11 October, 2023
Renalyse has successfully closed an investment round of 1 M€ with the participation of GENESIS Ventures ... 09 October, 2023
GENESIS Tech Transfer Boost invests €25,000 in the biotech company Spinally Medical ... 07 June, 2023
The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages ... 21 March, 2023
GENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of the National Awards El Suplemento ... 21 June, 2022
